| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |